6Day CP, James OF. Steatohepatitis : a tale of two “hit”[ J ] .9 Gastroenterology, 1998,114 (4) : 842-845.
7Marchesini G, Bfizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance [J]. Am J Med,1999,107 (5) : 450-455.
8Lin HZ , Yang SQ, Chuckaree C, et al. Metformin treatment reverses fatty liver disease in obese leptin-deficient mice [ J ]. Nature Med, 2000,6(9) :998-1003.
9Cohen B, Novick D, Rubinstein M. Modulation of insulin activity by leptin [ J ]. Science, 1996,274 (5290) : 1185-1188.
10Quadri R, Ruddia-Brandt L, Abid K, et al. Detection of the negativestrand hepatitis C virus RNA in tissues: implacation for pathogenesis[J] . Antiviral Res,2001,52(2) :161-171.
二级参考文献14
1Kopelaman P. Obesity as a medical problem. Nature, 2000,404:635-643.
2Woods S, Seeley RJ, Porte D Jr, et al. Signals that regulate food intake and energy homeostasis. Science, 1998,395:1378-1383.
3Friedman J, Halaas JL. Leptin and the regulation of body weight.Nature, 1998,395: 763-770.
4Tartaglia L. The leptin receptor. J Biol Chem, 1997, 272: 6093-6096.
5Bado A, Levasseur S, Attoub S, et al. The stomach as a source of leptin. Nature, 1998,394: 790-793.
6Uysal KI, Wies Drock SM, Marino MU, et al. Protection from obesity-induced insulin resistances in mice lacking TNF-alpha function,Nature, 1997,389: 610-614.
7Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of non-alcoholic fatty liver disease with insulin resistance. Am J Med,1999,107: 450-455.
8Cohen B, Novick D, Rubinstein M. Modulation of insulin activity by leptin. Science, 1996,274:1185-1188.
9Kamohara S, Barcelin R, Halaas JL, et al. Acute stimulation of glucose metabolism in mice by letpin treatment. Nature, 1997,389:374-377.
10Muller G, Ertl J, Gerl M, et al. Leptin impairs metabolic actions of insulin in isolated rat adipocytes, J Biol Chem, 1997,272:10585-10593.
8Riikka L, Ronald B, Patricia I, et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes[J]. Am J Physiol Endocfinol Metab, 2006,291 : 282-290.
9Chitturi S, Farrell GC, Hashimoto E, et al. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines[J]. J Gastroenterol Hepatol,2007,22 ( 6 ) : 778-787.
10Guenther Bodan. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver[J]. Current Science Inc, 2006,6: 177-181.
